These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 1384456)
1. Expression of P-glycoprotein in normal muscle cells and myogenic tumors. Garberoglio C; Dudas M; Casper ES; Bertino J; Cordon-Cardo C Arch Pathol Lab Med; 1992 Oct; 116(10):1055-61. PubMed ID: 1384456 [TBL] [Abstract][Full Text] [Related]
2. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. Cordon-Cardo C; O'Brien JP; Boccia J; Casals D; Bertino JR; Melamed MR J Histochem Cytochem; 1990 Sep; 38(9):1277-87. PubMed ID: 1974900 [TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells. Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein. Arceci RJ; Stieglitz K; Bras J; Schinkel A; Baas F; Croop J Cancer Res; 1993 Jan; 53(2):310-7. PubMed ID: 7678072 [TBL] [Abstract][Full Text] [Related]
5. MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase. Rao VV; Anthony DC; Piwnica-Worms D Cancer Res; 1994 Mar; 54(6):1536-41. PubMed ID: 7511043 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression. Bodey B; Taylor CR; Siegel SE; Kaiser HE Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809 [TBL] [Abstract][Full Text] [Related]
7. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors. Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma. Rutledge ML; Robey-Cafferty SS; Silva EG; Bruner JM Mod Pathol; 1990 May; 3(3):298-301. PubMed ID: 1972985 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas. Niehans GA; Jaszcz W; Brunetto V; Perri RT; Gajl-Peczalska K; Wick MR; Tsuruo T; Bloomfield CD Cancer Res; 1992 Jul; 52(13):3768-75. PubMed ID: 1352183 [TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance gene transcript level, and P-glycoprotein expression in paediatric malignant mesenchymal tumours. McDowell H; Peuchmaur M; Dominici C; Flamant F Anticancer Res; 1993; 13(5C):1863-6. PubMed ID: 7903523 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. Thiebaut F; Tsuruo T; Hamada H; Gottesman MM; Pastan I; Willingham MC J Histochem Cytochem; 1989 Feb; 37(2):159-64. PubMed ID: 2463300 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies. Schinkel AH; Roelofs EM; Borst P Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638 [TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. van Kalken CK; Giaccone G; van der Valk P; Kuiper CM; Hadisaputro MM; Bosma SA; Scheper RJ; Meijer CJ; Pinedo HM Am J Pathol; 1992 Nov; 141(5):1063-72. PubMed ID: 1359789 [TBL] [Abstract][Full Text] [Related]
15. Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies. Grogan T; Dalton W; Rybski J; Spier C; Meltzer P; Richter L; Gleason M; Pindur J; Cline A; Scheper R Lab Invest; 1990 Dec; 63(6):815-24. PubMed ID: 1979362 [TBL] [Abstract][Full Text] [Related]
16. Significance of P-glycoprotein expression in childhood malignant tumors. Kucerová H; Sumerauer D; Drahokoupilová E; Pisková M; Bedrnícek J; Eckschlager T Neoplasma; 2001; 48(6):472-8. PubMed ID: 11949840 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Dias P; Parham DM; Shapiro DN; Tapscott SJ; Houghton PJ Cancer Res; 1992 Dec; 52(23):6431-9. PubMed ID: 1384962 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of vinculin in human rhabdomyosarcomas. Meyer T; Brinck U Gen Diagn Pathol; 1997 Feb; 142(3-4):191-8. PubMed ID: 9065583 [TBL] [Abstract][Full Text] [Related]
19. Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Tonin PN; Scrable H; Shimada H; Cavenee WK Cancer Res; 1991 Oct; 51(19):5100-6. PubMed ID: 1717137 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells. Mechtersheimer G; Barth T; Quentmeier A; Möller P Am J Pathol; 1994 Jun; 144(6):1172-82. PubMed ID: 7515557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]